William Blair downgraded GoHealth (GOCO) to Market Perform from Outperform. Q3 revenue and Medicare submissions were below the firm’s expectations as the company pulled back on new enrollment growth, aligning with insurer actions to prioritize profitability and member retention over board member expansion, the analyst tells investors in a research note. The firm added that it believes the decision to limit cash burn is prudent given he challenging market dynamic, though it downgrades the shares given market headwinds that will likely persist through 2026,unccertatinty on GoHealth’s ability to generate sustainable positive cash flow, and limited progress in diversifying its business model.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOCO:
- GoHealth downgraded to Market Perform from Outperform at William Blair
- GoHealth files to sell 4.77M shares of Class A common stock for holders
- GoHealth price target lowered to $10 from $20 at Noble Capital
- GoHealth, Inc. Reports Strategic Shift Amid Market Changes
- GoHealth’s Strategic Shift: Earnings Call Insights
